Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q37665974

about

The Natural Course of Non-Alcoholic Fatty Liver Disease Gender-based disparities in access to and outcomes of liver transplantation Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis.Non-alcoholic fatty liver disease: An expanded review NASH in Special Populations.NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease.External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.The influence of metabolic factors for nonalcoholic Fatty liver disease in women.Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells.The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease Palmiwon attenuates hepatic lipid accumulation and hyperlipidemia in a menopausal rat model.A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B.Gender-based differences in the relationship between fatty liver disease and atherosclerosis.Review article: the management of cirrhosis in women.Outcomes in liver transplantation: does sex matter?Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?Caring for children with NAFLD and navigating their care into adulthood.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis.Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients.Sex differences in the association of HIV infection with hepatic steatosis.Reproductive Aging and Hepatic Fibrosis Progression in HIV/Hepatitis C Virus Co-Infected Women.Clinical characteristics of patients with diabetes mellitus and fatty liver diagnosed by liver/spleen Hounsfield units on CT scan Liver disease in menopause.Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.Role of Estrogens in the Regulation of Liver Lipid Metabolism.Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study.Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.Influence of lifestyle-related diseases and age on the development and progression of non-alcoholic fatty liver disease.Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease

P2860

Q26746947-326278C7-2EE7-402B-AF4E-6CD1C140E3F1 Q28083778-2885E56E-DDA2-42A3-BC07-3A6CD8DAF446 Q30402192-399249B2-7980-4C90-B58D-975368BE67DB Q33789868-634B3DF4-C602-4F4E-AF59-86433638351D Q33815231-E20250C4-0B9F-4920-9DFE-87A00946A358 Q33844463-9E26107B-E6D2-418F-92B9-098E4668C70F Q34447506-44C381D2-E526-4F78-B47F-A7D51963BBBE Q35188136-C31635B1-8323-445A-B2C8-51A7850FD748 Q35564120-14793812-C9D9-4433-AA79-E8C834617542 Q35573397-03367F19-1FD0-451A-8D77-257022B52844 Q35850620-C18FFFF8-3B37-47D8-A28F-3C4B294B0434 Q36078507-B9301C95-3DF3-4FA7-967C-6B115253596F Q36838110-25301B8B-10FB-45DF-B762-3AF2074A9D02 Q36967762-BA1AEB1D-C15F-4EEF-8CFC-5A5D5D191725 Q37029735-1A5F7D95-9CC9-40CE-90DC-5B4780CFF7E7 Q37444202-D09CF236-6639-46B0-9AA3-21E52A95FDCF Q37725977-9F82CCB5-2E8A-453C-9C65-7BC1D7505EA9 Q38255043-4F33BA97-9E45-4725-91CD-CEBE7E6BBF05 Q38272589-FE499394-D3E3-4912-994B-E9A33FE444E2 Q38507866-C495C918-7EB8-4DD9-8CA0-EBD3C1B147E7 Q38577570-102DE9F5-1C6C-4238-B3EF-80258DEDE7BD Q38752520-4AEDEABE-B751-491C-BF75-5435D24AD8D7 Q39358916-F3B8193F-C4C3-4561-A84C-C55C5B5A90D2 Q39491325-91FAFB5B-E2FA-49C5-9DDF-0AEB808405EA Q40074576-4C6370C4-12E4-45D6-ADC7-EAAB6CD7A566 Q40457566-3E467945-C18B-4C06-8A9A-54D6F067F787 Q41919094-F56377B4-7670-4AE4-849A-2B6895DAD82E Q42089836-2E0718C0-2501-4B59-8B21-2672BBCDA034 Q42359764-9443BBBB-8E24-4FDA-9B86-0434FC8BCE83 Q46003417-141151ED-21DF-4923-8148-B0BF2C95E5F9 Q47136445-BC0C5769-393C-482D-9768-0F1AB69F818F Q47311531-ADFCD2D8-3F8F-42D7-B066-E8AAACFA8C95 Q47631022-9F67222B-F7C5-44FB-8740-9A1DA44A50B7 Q51034522-17C309B1-3A8B-41FC-80E3-4B904F92C51F Q51130999-F58D1809-E859-4F73-BC19-8C2E60C42D8C Q57068205-81938A3B-BF85-4B68-A51D-1220EA8CE352

P2860

Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q37665974

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gender and menopause impact se ...... nonalcoholic steatohepatitis.

@en

Gender and menopause impact se ...... nonalcoholic steatohepatitis.

@nl

type

label

Gender and menopause impact se ...... nonalcoholic steatohepatitis.

@en

Gender and menopause impact se ...... nonalcoholic steatohepatitis.

@nl

prefLabel

Gender and menopause impact se ...... nonalcoholic steatohepatitis.

@en

Gender and menopause impact se ...... nonalcoholic steatohepatitis.

@nl

P1433

Q37665974-4DF1519D-0B01-40CD-AC37-77DA77BF574B

P1476

Q37665974-2AFBBFC8-975C-4F4C-A70E-A1DCAB10A967

P2093

Q37665974-064E99A7-5F13-4F1D-8A60-71DCA0EF0A76

Q37665974-4842C0F2-F746-455B-A97B-1E93E04AB943

Q37665974-54C2665B-4417-4F62-971D-4D85DA371BB7

Q37665974-671A2331-1AAF-41F3-B7B8-952154E62E7B

Q37665974-CDA4998E-796A-4136-90DC-6F9CBBD9E56A

P2860

Q37665974-048A4ED6-1E78-464F-82D2-A3BEA2AE8D55

Q37665974-1844559F-9C0A-42EE-B18B-D93C9229DD58

Q37665974-2DDBB520-78FA-4949-B5E1-8E36D5661DEF

Q37665974-3C9F8FD2-23C4-4828-AF94-2F793225BE2B

Q37665974-4092D662-3069-45A7-9640-B8B92DD06D7F

Q37665974-519980C6-8C9D-4D66-AB26-CC0C92582ABD

Q37665974-56949A46-4601-407F-9857-8B00F15E6468

Q37665974-5C91AF50-FEC2-45EC-9DAD-702F16703DDB

Q37665974-5F5CB8A1-3F0C-4A0D-A8D4-080A64F38210

Q37665974-6C9AE036-5A0C-47FD-B686-EDE8B7E0D6BA

P304

Q37665974-F751BCF3-F5E0-4F37-886C-3DC5E30D7D87

P31

Q37665974-EF728A02-F19E-4100-9E1C-1A5DE48E2AD9

P356

Q37665974-2112FF9B-292E-4D70-987C-C46444164DE4

P407

Q37665974-AEDC4313-D431-4CD7-AF11-16A5A9E856C8

P433

Q37665974-2964908F-D491-486C-8CB4-D7EB16EF6C7A

P478

Q37665974-73870608-BFAC-4DD9-B21D-48DCA426F5E7

P50

Q37665974-1BFA6CD6-52F4-4FFA-9EF5-F9A3A4B8E816

Q37665974-992D0EED-23A2-4AEF-9A93-C99439447FD5

P577

Q37665974-3DFFA421-ECB1-48CF-94D3-2BFF4C98A167

P698

Q37665974-A7646763-82DF-49F9-B7F4-64C1D57D0813

P921

Q37665974-2C1492D9-0071-473A-BF7B-E8E418179D8A

Q37665974-4B82165D-C4C5-4DA4-9AB2-F04F811B5B11

P932

Q37665974-60EB1365-F591-4A51-A1F4-63294E660FF8

P356

P1433

P1476

Gender and menopause impact se ...... h nonalcoholic steatohepatitis

@en

P2093

Alastair D Smith

http://www.w3.org/2001/XMLSchema#string

Anna Mae Diehl

http://www.w3.org/2001/XMLSchema#string

Ayako Suzuki

http://www.w3.org/2001/XMLSchema#string

Cynthia D Guy

http://www.w3.org/2001/XMLSchema#string

Ju Dong Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background.

Increased visceral fat and decreased energy expenditure during the menopausal transition

Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells.

Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.

Association between puberty and features of nonalcoholic fatty liver disease.

Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease.

P304

1406-1414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26761

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Manal F Abdelmalek

P577

2014-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24123276

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

3966932

http://www.w3.org/2001/XMLSchema#string